Register: bit.ly/3tymltK

Gender and socioeconomic differences affect a country's ability to support its older adult population. Specifically, the longevity risk associated with females' longer life expectancy entails different needs between genders in old age. In the first project, we aimed to quantify gender differences in the aging experience of OECD countries. Our second project compares differences in projections of disability and chronic diseases among future cohorts of older adults, including disparities by educational attainment. The model projected future chronic diseases and disability trends in Singapore and South Korea from 2020 to 2050. This presentation focuses on gender and socioeconomic differences in aging.

Using administrative data on over 4 million hospital visits, we document striking gender disparities within a government health insurance program that entitles 46 million poor individuals to free hospital care in Rajasthan, India. Females account for only 33% of hospital visits among children and 43% among the elderly. These shares are lower for more expensive types of care, and far lower than sex differences in illness prevalence can explain. Almost two-thirds of non-childbirth spending is on males. We combine these data with patient survey, census, and electoral data to show that 1) the program is unable to fully offset the costs of care-seeking, which results in disparities in hospital utilization because some households are willing to allocate more resources to male than female health; 2) lowering costs does not reduce disparities, because males benefit as much as females do; and 3) long-term exposure to village-level female leaders reduces the gender gap in utilization, but effects are modest and limited to girls and young women. In the presence of gender bias, increasing access to and subsidizing social services may increase levels of female utilization but fail to address gender inequalities without actions that specifically target females.

This event is part of the 2022 Spring webinar series, Negotiating Women's Rights and Gender Equality in Asia, sponsored by the Walter H. Shorenstein Asia-Pacific Research Center.

Bhutan time: Friday, February 4th, 2022, 8am to 9am.

Asia Health Policy Program (AHPP) 2021-22 Colloquium series "Aligning Incentives for Better Health and More Resilient Health Systems in Asia”

The Minister of Health of Bhutan, Her Excellency Dasho Dechen Wangmo, will share her insights and experiences from managing the national health system during the COVID-19 crisis, serving as President of the 74th World Health Assembly, and her views on health system strengthening, innovative primary care, chronic disease control, health governance, and the global implications of the pandemic as it unfolds in its third year.

Her Excellency Dasho Dechen Wangmo, the only female Minister in the current cabinet of Bhutan, formally took charge of the Ministry of Health on 7th November 2018. Prior to joining politic in 2018, Her Excellency worked as a public health international consultant with primary focus on health systems, governance, policy and strategic planning for governments and civil societies in many countries (USA, India, Nepal, Bangladesh, PNG, Myanmar, Sri Lanka, Thailand, Senegal). She brings her background working on various global health issues including health system strengthening, health governance, grant implementation, monitoring and evaluation system to the current portfolio.

On 17th December 2020 in recognition of her outstanding service to the Nation, she was conferred the “Red Scarf”, one of highest honors a Bhutanese civilian can receive, by His Majesty the King. Her Excellency is a passionate public health advocate and social worker at heart. Hon’ble Lyonpo was nominated as the President of the 74th World Health Assembly (WHA) by Member States of the WHO’s South East Asia Region in 2020. She will hold the office of the President for a duration of one year and it is an honour bestowed on Bhutan for the first time since it became a member of the WHO in 1982.

In addition to her memberships in professional organizations, she is also a founder of the Bhutan Cancer Society, a CSO working for the well being of cancer patients in Bhutan, and a founding chairperson for Lhaksam, the HIV-positive network in the country. Her Excellency has a Master in Public Health (MPH) from Yale School of Public Health, New Haven, USA, and a Bachelor in Cardiopulmonary Science (magna cum laude) from Northeastern University, Boston, USA.

Few aspects of society are being transformed by technology more than health and medical care, with health systems challenged to finance and deliver affordable access to a burgeoning array of technologies enabling longer, healthier lives. Three speakers will address different and complementary aspects of how several Asian health systems create, evaluate, and regulate transformative technologies. Dr. Masuda’s research probes policies governing domestic and cross-border control and sharing of genetic information for medical innovation. Dr. Ahn will discuss health technology assessment (HTA) for pricing and reimbursement decisions in South Korea, where there is a young yet established HTA program, compared to Japan, where a 3-year HTA pilot program has just concluded, and China, where HTA efforts are underway but have not been formally implemented. Finally, Dr. Ho will discuss the emergence of digital medicine enabling N-of-1 regimen design for patients. Truly individualizing patient treatment requires addressing a series of challenges, from dynamic patient response to treatment regimens, to accounting for drug synergies in combination therapies which can be dose-dependent, time-dependent, and patient-specific, such as in oncology. Dr. Ho will summarize several clinical studies aiming to increase accessibility to personalized, precision medicine while reducing healthcare costs.

Sachiko Masuda is a Visiting Scholar at the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) for the 2021-22 academic year and an Associate Professor at the University of Tokyo, Research Center for Advanced Science and Technology.  Masuda is dedicated to the study of legal systems, regulations, infrastructure and industrial structures necessary for advances in technology and a safer society, especially in the pharmaceutical and medical fields. At Shorenstein APARC, she is conducting a comparative Japan-U.S. study on "Human Genetic Information for Medical Innovation: Examining Policy Issues Related to Ensuring Domestic and Transnational Sharing and Management" supported by the ABE Fellowship Program of the Social Science Research Council. Masuda received a Ph.D. (specializing in intellectual property law) in 2006 and a B.S. in Pharmaceutical Sciences in 1997 from the University of Tokyo.

Dr. Jeonghoon Ahn is a full professor at the Ewha Womans University (Seoul, Korea) and an adjunct fellow at the National Evidence-based healthcare Collaborating Agency (NECA), Seoul, Korea. He is an expert on health technology assessment (HTA) and health economics. He worked 7 years in NECA and served in various decision making and advisory committees of public agencies such as the Health Insurance Review and Assessment Services (HIRA) and the Korean Centers for Disease Control (KCDC). Professor Ahn has graduated the Seoul National University Department of International Economics for undergraduate and master program. He also received a PhD in Economics from the University of Southern California (USC) and was an assistant professor of pharmaceutical economics and Policy at the USC. Dr. Ahn has served on many international professional organizations such as ISPOR, HTAi, INAHTA, and HTAsiaLink. He is the Chair of the ISPOR Asia Consortium (2020-2022) and was a president of ISPOR Korea Chapter (2012-2014). Dr. Ahn was elected as a board director of the Health Technology Assessment International (HTAi) (2014-2016) and a board director for the International Network of Agencies for Health Technology Assessment (INAHTA) for three times (2012-2016). He also contributed to form a regional Health Technology Assessment agency network, the HTAsiaLink (www.htasialink.org), along with other experts in the region.

Professor Dean Ho is currently Provost’s Chair Professor, Director of The N.1 Institute for Health (N.1), Director of The Institute for Digital Medicine (WisDM) and Head of the Department of Biomedical Engineering at the National University of Singapore. Prof. Ho and collaborators successfully developed and validated CURATE.AI, a powerful digital medicine platform that has optimized human treatment for broad indications ranging from oncology to infectious diseases. He co-led the first inhuman clinical trials that have resulted in completely halted disease progression and durable patient responses that substantially outperformed standard of care approaches. Prof. Ho is a Fellow of the US National Academy of Inventors (NAI), the American Institute for Medical and Biological Engineering (AIMBE), and the Royal Society of Chemistry. He was also recently named to the HIMSS Future50 Class of 2021 for his internationally-recognised leadership in digital health. His discoveries have been featured on CNN, The Economist, National Geographic, Forbes, Washington Post, NPR and other international news outlets. Prof. Ho is also a Subgroup Lead in the World Health Organization (WHO)-ITU AI for Health Working Group for Regulatory Considerations. Prof. Ho is a recipient of the Tech Heroes from Crisis Pathfinder Award from the Singapore Computer Society, NSF CAREER Award, Wallace H. Coulter Foundation Translational Research Award, and V Foundation for Cancer Research Scholar Award, among others. He has also served as the President of the Board of Directors of the Society for Laboratory Automation and Screening (SLAS), a 26,000+ member global drug development organization.

This event is part of the 2022 Winter webinar series, New Frontiers: Technology, Politics, and Society in the Asia-Pacific, sponsored by the Walter H. Shorenstein Asia-Pacific Research Center.

Asia Health Policy Program (AHPP) 2021-22 Colloquium series "Aligning Incentives for Better Health and More Resilient Health Systems in Asia”

How can policymakers quantify the net value of medical spending? For what medical conditions has the “bang for the buck” been greatest, and for what conditions has spending outstripped gains in health improvement? Join this virtual workshop to learn about cutting-edge methods that can be applied to health system data to understand the net value of changes in medical spending over time, and how policymakers can track the effectiveness of policies to increase productivity of medical spending. In addition to several Asian policymakers already involved, virtual workshop participants will have the opportunity to pose questions to the expert speakers about applying these methods to their own health system settings, including advice about data, outcomes, and relevance for specific policy questions.

David Cutler is the Otto Eckstein Professor of Applied Economics in the Department of Economics, Harvard University, with secondary appointments at the Kennedy School of Government and the School of Public Health. He was associate dean of the Faculty of Arts and Sciences for Social Sciences from 2003-2008. Professor Cutler served on the Council of Economic Advisers and the National Economic Council during the Clinton Administration and has advised several presidential campaigns, including as Senior Health Care Advisor for the Obama Presidential Campaign. He is a Research Associate at the National Bureau of Economic Research and a member of the Institute of Medicine, and he has held positions with the National Institutes of Health and the National Academy of Sciences

Abe Dunn is the Assistant Chief Economist at the Bureau of Economic Analysis.  His work has focused on the production and development of a new satellite account for health care and on evaluating and using alternative data sources for measurement purposes.  The Health Care Satellite Account uses billions of medical care claims from public and private sources to improve measurement for the U.S. health care sector, which allows researchers to analyze spending trends by medical condition.  Dr. Dunn has published research on a range of topics with a particular focus on health economic issues and measurement.  Most recently, his research has focused on measuring both the cost and the quality of medical care treatments. He received his PhD from the University of Texas at Austin with a primary focus in the areas of health economics and industrial organization.

Professor Marcia Weaver earned a PhD in economics at the University of Chicago. She specializes in cost-effectiveness analysis and has published 87 peer-reviewed articles. At the Institute for Health Metrics and Evaluation (IHME), she leads the research team on cost-effectiveness analyses of interventions to reduce the burden of disease. Prior to joining IHME she served as principal investigator of the Integrated Infectious Disease Capacity Building Evaluation in partnership with the Infectious Diseases Institute in Uganda. In the United States, she published on cost-effectiveness of interventions for people with HIV, chronic mental illness and substance abuse, and on a joint campaign to promote influenza and pneumococcal vaccines. Professor Weaver also has extensive experience with evaluating the effects of clinical training programs in Botswana, Indonesia, Namibia, South Africa, Thailand, and the Caribbean region, and served as a long-term advisor on health system reform to ministries of health in Niger and Central African Republic.

Wednesday, November 17, 2021, 8:00am - 9:30am (Shanghai time)

Designing effective climate change mitigation and adaptation policies requires comprehensive assessment of the projected damages from climate change. However,  current climate policy is informed by outdated models lacking empirical grounding. In this talk, we use subnational mortality records across 40 countries to generate data-driven estimates of the global mortality consequences of climate change. We show that both extreme cold and extreme heat raise mortality rates, especially for the elderly, the poor, and populations that experience these extremes infrequently. These heterogeneous nonlinear responses to warming lead to highly differentiated projected impacts of climate change across the globe. In this talk we focus in particular on the Asia-Pacific region, where mortality risk generally rises with a warming climate, but projected damages differ substantially within and across countries. We conclude by demonstrating how these results can be used to inform local adaptation policy within an individual city, using Chengdu, China as a case study, and point to new developments in climate science that will enable future improvements in mortality risk assessment across Asia. 

Tamma Carleton is an Assistant Professor of Economics at the Bren School of Environmental Science and Management at the University of California, Santa Barbara. Her research combines economics with datasets and methodologies from remote sensing, data science, and climate science to quantify how environmental change and economic development shape one another. Tamma's current work focuses on climate change, water scarcity, and the use of remote sensing for global-scale environmental and socioeconomic monitoring. She is an active member of the Climate Impact Lab, an interdisciplinary team conducting an empirically-grounded global assessment of climate change impacts. Tamma joined the Bren School after a postdoc at the Energy Policy Institute at the University of Chicago. She holds a PhD in Agricultural and Resource Economics from the University of California, Berkeley, MSc.'s in Environmental Change and Management as well as Economics for Development from the University of Oxford, and a BA in Economics from Lewis & Clark College.

Jiacan Yuan is an Associate Professor of Climatology at the Department of Atmospheric and Oceanic Sciences at Fudan University, Shanghai, China. She is interested in understanding fundamental dynamical processes of the climate system and improving climate models, which could give us stronger predictive power and more accurate risk assessment of the changing climate. Jiacan’s current work focuses on understanding the physical processes and uncertainties in climate changes, with major emphases on compound heat-humidity extremes and sea level rise. She is also an active member of the Climate Impact Lab. Before joining Fudan University, Jiacan was an Assistant Research Professor at the Department of Earth and Planetary Sciences at Rutgers University. She holds a Ph.D. in Meteorology from Peking University.

 This event is part of the 2021 Fall webinar series, Perfect Storm: Climate Change in Asia, sponsored by the Walter H. Shorenstein Asia-Pacific Research Center.

Asia Health Policy Program (AHPP) 2021-22 Colloquium series "Aligning Incentives for Better Health and More Resilient Health Systems in Asia”

Friday, November 12, 2021, 7:30am - 8:30am (Jakarta time)

Dr. Alatas will discuss her research on promoting vaccination in Indonesia and the impact of the pandemic on Indonesia’s society and economy more generally, including on poverty, human capital, and development.

Vivi Alatas is an  economist with passion for evidence-based solutions.  She is CEO of Asakreativita, a consulting and Edtech company that she established in 2020. Formerly she was a Lead Economist of the World Bank, where she led a team of seasoned local and international economists in producing several flagship reports for national and global audiences, including ‘Targeting Poor and Vulnerable Households in Indonesia’, ‘Making Poverty Work in Indonesia’ , ‘Indonesia’s Rising Divide’, ‘Indonesia Jobs Report’ and “Aspiring Indonesia – Expanding the Middle Class”. She has presented various of these research findings to the President, Vice President, Ministers and Deputy Ministers. She also has written several journal articles on poverty, inequality and labour issues. Some of the papers were written in collaboration with Nobel Laureates Abhijit Banerjee and Angus Deaton (who was also her advisor at Princeton).